In fact, most of the lipogenic genes were up‐regulated in MASLD patients such as FASN, SCD, FADS1&2, ELOVL5 (Figure 5E) in addition to MLYCD, ACACA (Figure S7C). This evidence concerns the gene ELOVL5 and metabolic dysfunction-associated steatotic liver disease.